Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Jackson

Showing results (81-90 of 182) with videos related to

Pageof 19
Sort By:
The Journal of Allergy and Clinical Immunology|October 1, 2025
Asthma remission in the context of other immune-mediated diseasesJosef Smolen, Bruce E Sands, Daniel J Jackson, et al.
The European Respiratory Journal|March 29, 2020
Prevalence and recovery of adrenal insufficiency in steroid-dependent asthma patients receiving biologic therapyAlexandra M Nanzer, Aqib Chowdhury, Asma Raheem, et al.
Thorax|July 5, 2022
In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infectionHugo Farne, Lijing Lin, David J Jackson, et al.
Allergy|May 14, 2025
Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled AsthmaJessica Gates, Faizan Haris, Francesca Cefaloni, et al.
NPJ Primary Care Respiratory Medicine|March 4, 2023
Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthmaJohn Haughney, Trung N Tran, Heath Heatley, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 6, 2025
Adherence to Inhaled Corticosteroids and Clinical Outcomes Following a Year of Tezepelumab Therapy for Severe AsthmaGrainne d'Ancona, Faizan Haris, Jessica Gates, et al.
Thorax|December 10, 2020
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic eraDavid J Jackson, John Busby, Paul E Pfeffer, et al.
ERJ Open Research|January 21, 2026
Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from the UK Severe Asthma RegistryPaul E Pfeffer, Jola Karaj, Thomas Brown, et al.
Chest|September 4, 2020
Real-World Effectiveness of Benralizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Andrew P Hearn, Jaideep Dhariwal, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2016
Matrix Metalloproteinase-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma SeverityShams-Un-Nisa Naveed, Debbie Clements, David J Jackson, et al.
Pageof 19

Showing results (81-90 of 182) with videos related to

Sort By:
Pageof 19
The Journal of Allergy and Clinical Immunology|October 1, 2025
Asthma remission in the context of other immune-mediated diseasesJosef Smolen, Bruce E Sands, Daniel J Jackson, et al.
The European Respiratory Journal|March 29, 2020
Prevalence and recovery of adrenal insufficiency in steroid-dependent asthma patients receiving biologic therapyAlexandra M Nanzer, Aqib Chowdhury, Asma Raheem, et al.
Thorax|July 5, 2022
In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infectionHugo Farne, Lijing Lin, David J Jackson, et al.
Allergy|May 14, 2025
Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled AsthmaJessica Gates, Faizan Haris, Francesca Cefaloni, et al.
NPJ Primary Care Respiratory Medicine|March 4, 2023
Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthmaJohn Haughney, Trung N Tran, Heath Heatley, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 6, 2025
Adherence to Inhaled Corticosteroids and Clinical Outcomes Following a Year of Tezepelumab Therapy for Severe AsthmaGrainne d'Ancona, Faizan Haris, Jessica Gates, et al.
Thorax|December 10, 2020
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic eraDavid J Jackson, John Busby, Paul E Pfeffer, et al.
ERJ Open Research|January 21, 2026
Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from the UK Severe Asthma RegistryPaul E Pfeffer, Jola Karaj, Thomas Brown, et al.
Chest|September 4, 2020
Real-World Effectiveness of Benralizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Andrew P Hearn, Jaideep Dhariwal, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2016
Matrix Metalloproteinase-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma SeverityShams-Un-Nisa Naveed, Debbie Clements, David J Jackson, et al.
Pageof 19